Trade Summary

Yesterday, Klein Lawrence Otto, serving as Chief Executive Officer at Oruka Therapeutics, Inc. (ORKA), sold 1,729 shares at $69.69 per share, for a total transaction value of $120,494.01. Following this transaction, Klein Lawrence Otto now holds 925,580 shares of ORKA.

This sale represents a 0.19% decrease in Klein Lawrence Otto's stake in the company.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 6:52 PM ET, meaning the disclosure happened on the same day as the trade.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.